Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial.
Takeshita Y, Honda M, Harada K, Kita Y, Takata N, Tsujiguchi H, Tanaka T, Goto H, Nakano Y, Iida N, Arai K, Yamashita T, Mizukoshi E, Nakamura H, Kaneko S, Takamura T. Takeshita Y, et al. Among authors: nakano y. Diabetes Care. 2022 Sep 1;45(9):2064-2075. doi: 10.2337/dc21-2049. Diabetes Care. 2022. PMID: 35894933 Free PMC article. Clinical Trial.
Increased visceral adiposity with normal weight is associated with the prevalence of non-alcoholic fatty liver disease in Japanese patients with type 2 diabetes.
Bouchi R, Takeuchi T, Akihisa M, Ohara N, Nakano Y, Nishitani R, Murakami M, Fukuda T, Fujita M, Minami I, Mihara M, Yoshimoto T, Ogawa Y. Bouchi R, et al. Among authors: nakano y. J Diabetes Investig. 2016 Jul;7(4):607-14. doi: 10.1111/jdi.12443. Epub 2015 Dec 19. J Diabetes Investig. 2016. PMID: 27182043 Free PMC article.
Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial.
Bouchi R, Nakano Y, Fukuda T, Takeuchi T, Murakami M, Minami I, Izumiyama H, Hashimoto K, Yoshimoto T, Ogawa Y. Bouchi R, et al. Among authors: nakano y. Endocr J. 2017 Mar 31;64(3):269-281. doi: 10.1507/endocrj.EJ16-0449. Epub 2016 Dec 3. Endocr J. 2017. PMID: 27916783 Free article. Clinical Trial.
Effects of eicosapentaenoic acid on serum levels of selenoprotein P and organ-specific insulin sensitivity in humans with dyslipidemia and type 2 diabetes.
Takeshita Y, Teramura C, Kamoshita K, Takayama H, Nakagawa H, Enyama Y, Ishii KA, Tanaka T, Goto H, Nakano Y, Osada S, Tanaka Y, Tokuyama K, Takamura T. Takeshita Y, et al. Among authors: nakano y. J Diabetes Investig. 2022 Mar;13(3):532-542. doi: 10.1111/jdi.13699. Epub 2021 Nov 9. J Diabetes Investig. 2022. PMID: 34670012 Free PMC article. Clinical Trial.
Insulin-glucagon-like peptide-1 receptor agonist relay and glucagon-like peptide-1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open-label trial study.
Takeshita Y, Kita Y, Tanaka T, Goto H, Nakano Y, Teramura C, Enyama Y, Takamura T; Establishment of Rationale for Antiaging Diabetic Medicine (ERA-DM) Study Group. Takeshita Y, et al. Among authors: nakano y. J Diabetes Investig. 2022 Jun;13(6):965-974. doi: 10.1111/jdi.13749. Epub 2022 Feb 8. J Diabetes Investig. 2022. PMID: 35034428 Free PMC article. Clinical Trial.
Somatostatin Receptor-negative and Fluorodeoxyglucose-positron Emission Tomography-positive Lung Neuroendocrine Tumor G1 Exhibiting Cyclic Cushing's Syndrome.
Nomura C, Nakano Y, Tanaka T, Shima KR, Kometani M, Kanamori T, Ikeda H, Takeshita Y, Yoneda T, Takamura T. Nomura C, et al. Among authors: nakano y. Intern Med. 2022 Dec 15;61(24):3693-3698. doi: 10.2169/internalmedicine.9238-21. Epub 2022 May 31. Intern Med. 2022. PMID: 35650126 Free PMC article.
Selenoprotein P deficiency protects against immobilization-induced muscle atrophy by suppressing atrophy-related E3 ubiquitin ligases.
Abuduwaili H, Kamoshita K, Ishii KA, Takahashi K, Abuduyimiti T, Qifang L, Isobe Y, Goto H, Nakano Y, Takeshita Y, Takayama H, Harada K, Takamura T. Abuduwaili H, et al. Among authors: nakano y. Am J Physiol Endocrinol Metab. 2023 Jun 1;324(6):E542-E552. doi: 10.1152/ajpendo.00270.2022. Epub 2023 Mar 22. Am J Physiol Endocrinol Metab. 2023. PMID: 36947851
PAC1 Deficiency Protects Obese Male Mice From Immobilization-Induced Muscle Atrophy by Suppressing FoxO-Atrogene Axis.
Li Q, Ishii KA, Kamoshita K, Takahashi K, Abuduwaili H, Takayama H, Galicia-Medina CM, Tanida R, Ko Oo H, Gafiyatullina G, Yao X, Abuduyimiti T, Hamazaki J, Goto H, Nakano Y, Takeshita Y, Harada K, Murata S, Takamura T. Li Q, et al. Among authors: nakano y. Endocrinology. 2023 Apr 17;164(6):bqad065. doi: 10.1210/endocr/bqad065. Endocrinology. 2023. PMID: 37103220 Free PMC article.
3,537 results